Benefit finding in long-term prostate cancer survivors

Saved in:
Bibliographic Details
Title: Benefit finding in long-term prostate cancer survivors
Authors: Irène Lassmann, Andreas Dinkel, Birgitt Marten-Mittag, Matthias Jahnen, Helga Schulwitz, Jürgen E. Gschwend, Kathleen Herkommer
Source: Support Care Cancer
Publisher Information: Springer Science and Business Media LLC, 2021.
Publication Year: 2021
Subject Terms: Male, 03 medical and health sciences, 0302 clinical medicine, Cancer Survivors, 4. Education, Quality of Life, Humans, Prostatic Neoplasms, Original Article, Cancer Survivors/psychology [MeSH], Cancer survivor, Aged [MeSH], Posttraumatic growth, Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Quality of Life/psychology [MeSH], Benefit finding, Male [MeSH], Prostatic Neoplasms/psychology [MeSH], Prostate cancer, Urological malignancy, ddc, Aged, 3. Good health
Description: PurposeBenefit finding (BF) represents possible positive changes that people may experience after cancer diagnosis and treatment and has proven to be valuable to the psychological outcome. Knowledge of such beneficial consequences of prostate cancer (PCa) is limited in long-term survivors (> 5 years). Thus, the present study investigated the occurrence of benefit finding (BF) and its determinants in a large sample of (very-) long-term PCa survivors.MethodsBF was assessed in 4252 PCa survivors from the German database “Familial Prostate Cancer” using the German version of the Benefit Finding Scale (BFS). Associations between BF and sociodemographic, clinical, and psychosocial (e.g., depressive and anxiety symptoms and perceived severity of the disease experience) variables were analyzed using hierarchical multiple linear regression analysis.ResultsMean age at survey was 77.4 years (SD = 6.2) after a mean follow-up of 14.8 years (SD = 3.8). Mean BFS score was 3.14 (SD = 1.0); the prevalence of moderate-to-high BF (score ≥ 3) was 59.7%. Younger age at diagnosis, lower educational level, and higher perceived severity of the disease experience were predictive of BF. Objective disease severity or family history of PCa was not uniquely associated with BF.ConclusionsBF occurs in older, (very-) long-term PCa survivors. Our findings suggest that the self-asserted severity of the disease experience in a patient’s biography is linked to BF in the survivorship course above all tangible sociodemographic and clinical factors.Implications for cancer survivorsPCa survivors may express BF regardless of clinical disease severity. Treating urologists should consider inquiring BF to enrich a patient’s cancer narrative.
Document Type: Article
Other literature type
File Description: application/pdf
Language: English
ISSN: 1433-7339
0941-4355
DOI: 10.1007/s00520-020-05971-3
Access URL: https://link.springer.com/content/pdf/10.1007/s00520-020-05971-3.pdf
https://pubmed.ncbi.nlm.nih.gov/33447865
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236447
https://pubmed.ncbi.nlm.nih.gov/33447865/
https://www.scilit.net/article/c897e426fd1e8d58140f2c09af2809bb?action=show-references
https://link.springer.com/article/10.1007/s00520-020-05971-3
https://link.springer.com/content/pdf/10.1007/s00520-020-05971-3.pdf
https://repository.publisso.de/resource/frl:6446694
https://mediatum.ub.tum.de/doc/1637986/document.pdf
Rights: CC BY
Accession Number: edsair.doi.dedup.....6bd039caf55385d31267fd9024c5818f
Database: OpenAIRE
Description
Abstract:PurposeBenefit finding (BF) represents possible positive changes that people may experience after cancer diagnosis and treatment and has proven to be valuable to the psychological outcome. Knowledge of such beneficial consequences of prostate cancer (PCa) is limited in long-term survivors (> 5 years). Thus, the present study investigated the occurrence of benefit finding (BF) and its determinants in a large sample of (very-) long-term PCa survivors.MethodsBF was assessed in 4252 PCa survivors from the German database “Familial Prostate Cancer” using the German version of the Benefit Finding Scale (BFS). Associations between BF and sociodemographic, clinical, and psychosocial (e.g., depressive and anxiety symptoms and perceived severity of the disease experience) variables were analyzed using hierarchical multiple linear regression analysis.ResultsMean age at survey was 77.4 years (SD = 6.2) after a mean follow-up of 14.8 years (SD = 3.8). Mean BFS score was 3.14 (SD = 1.0); the prevalence of moderate-to-high BF (score ≥ 3) was 59.7%. Younger age at diagnosis, lower educational level, and higher perceived severity of the disease experience were predictive of BF. Objective disease severity or family history of PCa was not uniquely associated with BF.ConclusionsBF occurs in older, (very-) long-term PCa survivors. Our findings suggest that the self-asserted severity of the disease experience in a patient’s biography is linked to BF in the survivorship course above all tangible sociodemographic and clinical factors.Implications for cancer survivorsPCa survivors may express BF regardless of clinical disease severity. Treating urologists should consider inquiring BF to enrich a patient’s cancer narrative.
ISSN:14337339
09414355
DOI:10.1007/s00520-020-05971-3